Ireland’s National Institute for Bioprocessing Research and Training launches GLP-1 receptor agonist-focused course.

According to a new analysis by Gallup, 11% of adults in the USA are currently using injectable GLP-1 or dual GIP–GLP-1 ...

Many telehealth platforms selling GLP-1s online prescribe the drugs without requiring a clinician to interact with the patient in real time, according to a secret shopper study conducted by ...

Few products have captured public interest as fast as GLP-1 receptor-agonist weight-loss drugs. But one unforeseen consequence of their popularity has been to create what is, in effect, one of the ...

Could GLP-1 drugs worsen ALS? Why weight loss may carry hidden risks GLP-1 drugs can help diabetes and obesity, but in ALS, weight loss may speed decline. New reports suggest doctors should be ...

Medicare patients are getting access to GLP-1s for obesity through the Bridge program. But questions linger regarding ...

The drugmaker said it would accept requests for early access to its experimental drug for some adults with severe obesity.

If a GLP-1 can change one brain this much, what happens when it changes 40 million? An evidence-based tour of America by 2030 ...

Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She's a certified sleep science coach and ...

Glucagon-like peptide-1 (GLP-1) receptor agonists were originally prescribed for type 2 diabetes (T2D), but several are now specifically approved for long-term weight management. Comparing how well ...